Sanofi
SNYNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $9 | $13 | $10 |
| Short-Term Investments | $0 | $0 | $1 | $1 |
| Receivables | $11 | $11 | $11 | $10 |
| Inventory | $9 | $10 | $9 | $9 |
| Other Curr. Assets | $15 | $1 | $1 | $1 |
| Total Curr. Assets | $43 | $31 | $34 | $31 |
| Property Plant & Equip (Net) | $12 | $12 | $12 | $12 |
| Goodwill | $43 | $49 | $50 | $48 |
| Intangibles | $23 | $24 | $15 | $21 |
| Long-Term Investments | $3 | $3 | $9 | $8 |
| Tax Assets | $8 | $6 | $5 | $5 |
| Other NC Assets | $1 | $1 | -$1 | -$4 |
| Total NC Assets | $90 | $96 | $90 | $90 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $133 | $126 | $125 | $120 |
| Liabilities | – | – | – | – |
| Payables | $8 | $7 | $7 | $6 |
| Short-Term Debt | $4 | $2 | $4 | $3 |
| Tax Payable | $1 | $1 | $1 | $0 |
| Deferred Revenue | $0 | $1 | $0 | $0 |
| Other Curr. Liab. | $16 | $13 | $12 | $11 |
| Total Curr. Liab. | $29 | $24 | $24 | $21 |
| LT Debt | $13 | $16 | $17 | $19 |
| Deferred Rev, NC | $0 | $0 | $8 | $9 |
| Deferred Tax Liab, NC | $2 | $0 | $2 | $2 |
| Other NC Liab. | $10 | $12 | $0 | $0 |
| Total NC Liab. | $26 | $28 | $28 | $30 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $55 | $52 | $51 | $51 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | $0 | $67 | $67 | $0 |
| AOCI | $71 | $5 | $68 | $62 |
| Other Equity | $4 | -$1 | -$1 | $4 |
| Total Equity | $78 | $74 | $75 | $69 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $133 | $126 | $125 | $120 |
| Net Debt | $10 | $10 | $8 | $12 |